[Rofecoxib-related cutaneous vasculitis]

Presse Med. 2005 Aug 27;34(14):1007-8. doi: 10.1016/s0755-4982(05)84101-6.
[Article in French]

Abstract

Introduction: Drugs are at the origin of around 10% of the cases of vasculitis involving the small vessels. Recent cases report vasculitis related to the administration of nonsteroidal antiinflammatory selective inhibitors of cyclo-oxygenase 2.

Case: Vasculitis associated with ketoprofen appeared in a 76 year-old man: the symptoms disappeared when treatment stopped. A few weeks later, during treatment with rofecoxib, a relapse appeared, including purpura. The diagnosis of rofecoxib-induced cutaneous vasculitis was confirmed by regression of all symptoms when treatment stopped.

Discussion: Coxibs, like other nonsteroidal antiinflammatory drugs, may cause vasculitis, at an as-yet undetermined frequency.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Arthritis / drug therapy
  • Cyclooxygenase Inhibitors / administration & dosage
  • Cyclooxygenase Inhibitors / adverse effects*
  • Drug Eruptions / etiology*
  • Humans
  • Lactones / administration & dosage
  • Lactones / adverse effects*
  • Male
  • Purpura / chemically induced
  • Sulfones / administration & dosage
  • Sulfones / adverse effects*
  • Time Factors
  • Vasculitis / chemically induced*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib